Evidence map›Paper›PMID 11283161›Full record

ArticleThe Journal of experimental medicine2001

V(D)J recombination becomes accessible.

M S Krangel

Abstract readComment
PubMed Full text at PMC Publisher
In one paragraph

Article in The Journal of experimental medicine, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. The T cell receptor beta enhancer promotes access and pairing of Dbeta and Jbeta gene segments during V(D)J recombination.Proceedings of the National Academy of Sciences of the United States of America · 2003
    Article
  3. A multistep mechanism for the activation of rearrangement in the immune system.Proceedings of the National Academy of Sciences of the United States of America · 2003
    Article
  4. Review
  5. Article
  6. Article
  7. Intermediates in V(D)J recombination: a stable RAG1/2 complex sequesters cleaved RSS ends.Proceedings of the National Academy of Sciences of the United States of America · 2001
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author.

M S KrangelDepartment of Immunology, Duke University Medical Center, Durham, North Carolina 27710, USA. krang001@mc.duke.edu

Funding

Control Of Tcr Delta And Tcr Alpha RearrangementR37GM041052 · NIGMS · DUKE UNIVERSITY · PI KRANGEL, MICHAEL S · 2006 to 2015
$5.1M
HUMAN GAMMA DELTA T CELL RECEPTORR01GM041052 · NIGMS · DUKE UNIVERSITY · PI KRANGEL, MICHAEL S · 1989 to 2019
$4.8M
NIGMS NIH HHS GM41052NIGMS NIH HHS R01 GM041052NIGMS NIH HHS R37 GM041052
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Recombination, GeneticGene Rearrangement, gamma-Chain T-Cell Antigen ReceptorReceptors, Antigen, T-Cell, gamma-deltaReceptors, Antigen, T-Cell, gamma-delta

Identifiers

PMID11283161
PMCPMC2193372

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.